Mitochonic acid 5 regulates mitofusin 2 to protect microglia

来源 :中国神经再生研究(英文版) | 被引量 : 0次 | 上传用户:lx305954308
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Microglial apoptosis is associated with neuroinflammation and no effective strategies are currently available to protect microglia against inflammation-induced apoptosis.Mouse microglial BV-2 cells(5 × 106)were incubated with 10 μg/mL lipopolysaccharides for 12 hours to mimic an inflammatory environment.Then the cells were co-cultured with mitochonic acid 5(MA-5)for another 12 hours.MA-5 improved the survival of lipopolysaccharide-exposed cells.MA-5 decreased the activity of caspase-3,which is associated with apoptosis.MA-5 reduced the number of terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling-positive cells,and increased adenosine triphosphate levels in cells.MA-5 decreased the open state of the mitochondrial permeability transition pore and reduced calcium overload and diffusion of second mitochondria-derived activator of caspase(Smac).MA-5 decreased the expression of apoptosis-related proteins(mitochondrial Smac,cytoplasmic Smac,pro-caspase-3,cleaved-caspase-3,and caspase-9),and increased the levels of anti-apoptotic proteins(Bcl2 and X-linked inhibitor of apoptosis protein),mitochondria-related proteins(mitochondrial fusion protein 2,mitochondrial microtubule-associated proteins 1A/1B light chain 3B Ⅱ),and autophagy-related proteins(Beclin1,p62 and autophagy related 5).However,MA-5 did not promote mitochondrial homeostasis or decrease microglial apoptosis when Mitofusin 2 expression was silenced.This shows that MA-5 increased Mitofusin 2-related mitophagy,reversed cellular energy production and maintained energy metabolism in BV-2 cells in response to lipopolysaccharide-induced inflammation.These findings indicate that MA-5 may promote the survival of microglial cells via Mitofusin 2-related mitophagy in response to lipopolysaccharide-induced inflammation.
其他文献
目的 基于全社会角度,对达可替尼相比其他表皮生长因子-酪氨酸激酶抑制剂(EGFR-TKIs)药物(吉非替尼、厄洛替尼、埃克替尼、阿法替尼和奥希替尼)一线治疗晚期非小细胞肺癌进行
质量调整生命年(QALY)和伤残调整生命年(DALY)是卫生项目经济分析中常用的多维健康效用指标,都可以作为健康效用用于成本-效用分析中.由于缺乏我国的成本-效用阈值,在某些以Q
目的 探讨阿托伐他汀钙片联合稳心颗粒治疗冠状动脉粥样硬化性心脏病对患者心功能及血流变指标的影响.方法 选取2019年4月至2020年3月于大化集团有限责任公司医院接受治疗的